6 people in the Netherlands with monkeypox There are now 6 cases of monkeypox in humans in the Netherlands. Science Photo Library / ANP
First patient with monkeypox in the Netherlands This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test. Science Photo Library / ANP
Even after COVID-19 crisis, social isolation continues Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
Decrease in SARS-CoV-2 hospital admissions, fewer people tested 1,214 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands in the past week*, a decrease of 12% compared to the week before that.
Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
Sewage treatment workers not more likely to carry antibiotic-resistant bacteria Employees at sewage and wastewater treatment plants in the Netherlands and Germany are not more likely to carry antibiotic-resistant bacteria than other people. Unie van Waterschappen
More hospital admissions, decrease in positive COVID-19 tests The number of new patients admitted to hospital with COVID-19 increased to 538 admissions last week. That is 266 more admissions than in the previous week.
Increase in hospital admissions, cautious stabilisation in positive COVID-19 tests In the past week from 14-20 July 2021, the reported number of people who tested positive for COVID-19 increased by 34% compared to the previous week.